Tech

Tempest Therapeutics, a clinical-stage oncology company specializing in the development of innovative therapeutics combining targeted and immune-mediated mechanisms, announced its financial results for the third

The Oncology Institute, a prominent value-based community oncology group in the United States, announced its financial results for the third quarter (Q3) and nine months

Assertio Holdings, a specialty pharmaceutical company known for its acquisition, commercialization, and development of safe and effective therapies, released its financial results for the third

In a report released yesterday, Acutus Medical, a prominent player in the field of arrhythmia management, disclosed its financial results for the third quarter (Q3)